Annual Progress Reports. LICENSEE shall provide LICENSOR with written annual reports within sixty (60) days after the end of each calendar year during the term of this Agreement to report on LICENSEE’s progress in developing and marketing Licensed Product. The obligation to submit such progress reports shall end upon the First Commercial Sale of Licensed Product.
Appears in 4 contracts
Samples: License Agreement (VistaGen Therapeutics, Inc.), License Agreement (VistaGen Therapeutics, Inc.), Option Agreement (VistaGen Therapeutics, Inc.)
Annual Progress Reports. LICENSEE shall provide LICENSOR with annual written annual progress reports within sixty (60) days after the end anniversary date of each calendar year the effective date of this agreement. The reports shall include sufficient detail to allow LICENSEE to determine progress on research and development, manufacturing, sublicensing, marketing and sales during the term of this Agreement to report on LICENSEE’s progress in developing and marketing Licensed Product. The obligation to submit such progress reports shall end upon previous twelve (12) months as well as plans for the First Commercial Sale of Licensed Productcoming year.
Appears in 1 contract
Samples: Exclusive License Agreement (Molecular Insight Pharmaceuticals, Inc.)
Annual Progress Reports. LICENSEE shall provide LICENSOR with annual written annual progress reports within sixty (60) days after the end anniversary date of each calendar year the effective date of this agreement. The reports shall include sufficient detail to allow LICENSOR to determine progress on research and development, manufacturing, sublicensing, marketing and sales during the term of this Agreement to report on LICENSEE’s progress in developing and marketing Licensed Product. The obligation to submit such progress reports shall end upon previous twelve (12) months as well as plans for the First Commercial Sale of Licensed Productcoming year.
Appears in 1 contract
Samples: exclusive License Agreement (China Rx Holdings, Inc.)